Companies Cryptocurrencies
Menlo Therapeutics Inc
Menlo Therapeutics Inc
Exchange: Nasdaq Global Select
IPO Date: 25/01/2018
CEO: Mr. David Domzalski
Biotechnology Healthcare 🔗
  • MNLO
    symbol
  • price
  • market cap
  • changes
If you bought

shares of Menlo Therapeutics Inc (MNLO) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company is headquartered in Redwood City, California and currently employs 42 full-time employees. The firm is focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions, such as atopic dermatitis, psoriasis and prurigo nodularis. The company is also evaluating the use of serlopitant for the treatment of refractory chronic cough. The Company’s serlopitant is a small molecule, highly selective NK1-R antagonist. The company is developing serlopitant as an once-daily oral tablet therapy. The firm has completed Phase II clinical trials in pruritus associated with atopic dermatitis.

Address: 520 U.S. Highway 22 Suite 204 Bridgewater NEW JERSEY 08807

Stay updated.